Drug Utilization Review Board
Meeting Agenda
Thursday, October 9, 2025
7:15 a.m. to 8:30 a.m.
Google Meet joining info
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306#
Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
1) Call to order - Sharon Weinstein, MD
a) Welcome and Introductions
b) Housekeeping - Luis Moreno, PharmD
c) Review and Approval of Minutes
2) P&T Committee Update - Ngan Huynh, PharmD
3) Review Topic
a) Oral Buprenorphine-Containing Products for Pain and Concurrent Use With Other Opioids - Monet Luloh, PharmD
i) Committee Discussion/Questions
ii) Committee Action
4) Public Comment
5) Review Prior Authorization Criteria
a) Omnipod 5 - Luis Moreno, PharmD
i) Committee Discussion/Questions
ii) Committee Action
b) Zevaskyn (prademagene zamikeracel) - Luis Moreno, PharmD
i) Committee Discussion/Questions
ii) Committee Action
c) Hympavzi (marstacimab-hncq) - Luis Moreno, PharmD
i) Committee Discussion/Questions
ii) Committee Action
6) Next Meeting
a) Date: November 13, 2025
b) Topic: Initiation of CGRP Antagonists plus Botox for migraine prophylaxis.
7) Adjourned - Sharon Weinstein, MD
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306#